{"code":"Q2054","short_description":"Lisocabtagene mara car pos t","long_description":"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose","status":"active","section":"Q-codes: Temporary Codes","category":"Temporary","effective_date":"2021-10-01","termination_date":null,"replacement_code":"","opps_status_indicator":"K","opps_status_label":"Non-pass-through drugs and biologicals","opps_apc":"9413","fee_schedules":[],"mue":[],"drug_classes":[],"ndc_crosswalk":[{"ndc":"73153-0900-01","drug_name":"Breyanzi","dosage":"UP TO 110 million CAR-positive viable T cells, per therapeutic dose","unit":"1","labeler_name":"Juno Therapeutics, Inc."}],"utilization":[],"urls":{"self_html":"https:\/\/hcpcslookup.com\/codes\/q2054","self_json":"https:\/\/hcpcslookup.com\/api\/codes\/Q2054.json"}}